Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research focusing on why estrogenic hormones produce differing results

14.02.2005


New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.



"It’s very difficult right now for women to make a choice about taking estrogen or other estrogen-like compounds, and, I think, it’s equally difficult for physicians to try to tell women what they should do," said Ann M. Nardulli, a professor in the department of molecular and integrative physiology at the University of Illinois at Urbana-Champaign.

Nardulli was the principal investigator of a study published in the Jan. 7 issue of the Journal of Biological Chemistry. In the study, Nardulli, doctoral student Jennifer R. Schultz and postgraduate researcher Larry N. Petz added fuel to the argument that the long-held model for how an estrogen receptor binds to DNA and, in turn, regulates gene transcription is need of retooling.


Nardulli’s team has found four discrete regions of the human progesterone receptor gene that confer hormone responsiveness. In the study, the activities of estradiol, tamoxifen, raloxifene and the soy phytoestrogens genestein and daidzein were examined and compared in uterine, mammary and bone cell lines. The researchers found vast differences based on the four regions. "The model has always been that the estrogen receptor binds to DNA to activate transcription, but now we show that that’s not always the case," Nardulli said. "Binding doesn’t occur equally well in different kinds of tissue, and it requires a broader vision on how transcription changes the functions in cells."

The value of hormone-replacement therapy has come under scrutiny because of links to various cancers. It’s also been discovered that women taking tamoxifen to protect against a relapse of breast cancer were more susceptible to getting uterine cancer. Other research, conducted at Illinois by food scientist William Helferich, has shown that the soy phytoestrogen genestein in doses similar to that found in supplements may negate the ability of tamoxifen to stop cancer redevelopment. Many women take soy supplements to control hot flashes.

The discovery in 1996 of a second estrogen receptor, or binding protein, began to rewrite conventional wisdom. Instead of just one receptor, now known as ER-alpha, researchers began studying the second one, ER-beta. ER-alpha is predominant in the uterus, liver, mammary gland, bone and cardiovascular systems; ER-beta is most expressed in the prostate, ovary and urinary tract.

Researchers also have found that many estrogen-responsive genes don’t have estrogen response elements -- long considered the cornerstone of estrogen receptor binding and transcription. Instead, as in the human progesterone receptor gene, they have multiple binding sites for activator proteins such as the four regions identified in Nardulli’s lab.

The four regions in progesterone receptor gene are known as AP-1 and Sp1 sites. The Sp1 sites, Nardulli said, are "pretty potent activators that get transcription going" when exposed to most of the hormones tested. The AP-1 sites by themselves were weak -- responsive somewhat to estrogen but not to the other hormones. Mutating an AP-1 site in the context of a larger gene region dramatically reduces transcription. Her lab’s findings also supported previous evidence that ER-alpha is much more potent than ER-beta.

"Turning on the expression of genes in a cell is not like turning on a light switch, because you have many different estrogen responsive genes in one cell," Nardulli said. "So, do you want to turn on all the genes to the same extent, or do you want to differentially regulate them? What researchers really would like to do is develop a hormone drug -- a ligand -- that targets exactly the tissues you want to affect without affecting any others."

Such work is already beginning to take shape in other labs at Illinois.

A team led by John A. Katzenellenbogen, a professor of chemistry, and his wife, Benita S. Katzenellenbogen, a professor of molecular and integrative physiology and of cell and structural biology in the College of Medicine at Urbana-Champaign, recently have produced a series of synthesized, non-steroidal estrogenic compounds that seek out and bind with ER-beta very selectively.

In a paper appearing online in advance of regular publication in the Journal of Medicinal Chemistry, published by the American Chemical Society, the Katzenellenbogens report that their compounds work on ER-beta nearly identically to estradiol, but they have almost no effect on the other estrogen receptor, ER-alpha.

"These compounds might prove useful as selective pharmacological probes to study the biological actions of estrogens mediated through ER-beta, and they might lead to the development of useful pharmaceuticals," they wrote in the journal paper.

Jim Barlow | EurekAlert!
Further information:
http://www.uiuc.edu

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>